Quidel

News Release

Printer Friendly Version View printer-friendly version
<< Back
Quidel Corporation Wins Prestigious Supplier of the Year Award; Award Recognizes Best Sales Growth in the Primary Care Market

SAN DIEGO, July 24 /PRNewswire/ -- Quidel Corporation (Nasdaq: QDEL), a leading provider of point-of-care (POC) rapid diagnostic tests, today announced that it was recently awarded the McKessonHBOC Medical Group Supplier of the Year Award for Best Growth in the primary care market. The award was presented to Quidel at McKessonHBOC's Supply Management Business National Sales Convention in Las Vegas, Nevada.

From more than 200 supplier partners, Quidel was recognized by McKessonHBOC, Inc. (NYSE: MCK), the world's largest healthcare services company, for demonstrating the best product-sales growth in the primary care market. Quidel was the sole winner in its category.

"Quidel's commitment to building strong field relationships enables McKessonHBOC Medical Group to better meet the needs of our customers," said Primary Care President Rick Frey. "Their offering of rapid testing products combined with their dedicated marketing focus helped us achieve our business goals."

"McKessonHBOC is a world leader in healthcare services and supply chain management, and we are proud to have been selected as its fastest growing supplier in the primary care market. This is testament to our goal of strengthening our marketing and distribution relationships and demonstrates increased market acceptance and demand for Quidel's products," said S. Wayne Kay, Quidel's President and Chief Operating Officer. "Furthermore, this award validates our commitment to develop and supply world-class products that exceed our customers' expectations. It is gratifying to know that our relationship is of great value to McKessonHBOC, and we look forward to strengthening our business partnership with them."

This award adds to Quidel's previous top-supplier awards from Allegiance Healthcare and Henry Schein Medical Group, Inc.

McKessonHBOC Medical Group Supplier of the Year Award for Best Growth, 2001

McKessonHBOC, Inc., a Fortune 35 corporation, is the world's largest supply management and healthcare information technology company.

Allegiance Healthcare Outstanding Sales Achievement Award, 2000

A Cardinal Health company, Allegiance Healthcare Corporation is a leading provider of healthcare products and cost-management services needed by hospitals, laboratories and others in healthcare.

Henry Schein Medical/Surgical Product Manufacturer of the Year, 1999

Henry Schein, Inc. is the largest distributor of healthcare products and services to office-based healthcare practitioners in the combined North American and European markets.

About Quidel Corporation
Quidel Corporation discovers, develops, manufactures and markets point-of- care, rapid diagnostic tests for detection of medical conditions and illnesses. These products provide accurate, rapid and cost-effective diagnostic information for acute and chronic conditions that affect women's health throughout the phases of their lives including reproductive status, pregnancy management and osteoporosis. Quidel also provides point-of-care diagnostics for infectious diseases, including influenza A and B, strep throat, H. pylori infection, chlamydia, infectious mononucleosis, and bacterial vaginosis. Quidel's products are sold to healthcare professionals for use in physicians' offices, clinical laboratories and pharmacies, and to consumers through organizations that provide private label, store brand products. These tests provide diagnostic information to enable rapid treatment and improve health outcomes, lower costs, and increase patient satisfaction. For more information, please visit Quidel's Web site at http://www.quidel.com.

This press release contains forward-looking statements regarding Quidel's future activities within the meaning of the federal securities laws. These forward-looking statements involve material risks and uncertainties. Many possible factors could affect the future results and performance of Quidel's business, such that actual results and performance may differ materially. If Quidel's products fail to perform as expected, or if there is lower consumer demand for these products than expected, Quidel's financial condition and operating results may be materially and adversely affected. Quidel's financial condition and operating results may also be materially and adversely affected by a number of other factors, including, without limitation, seasonality, adverse changes (both domestically and internationally) in competitive and economic conditions, actions by the Company's distributors, manufacturing and production delays or difficulties and adverse actions or delays in product reviews by the FDA. Please see the discussion of these and other factors in Quidel's annual report on Form 10-K and subsequent quarterly reports on Form 10-Q.

CONTACT:
Bruce Voss, bvoss@lhai.com,
or Martin Halsall, mhalsall@lhai.com,
both of Lippert/Heilshorn & Associates, +1-310-691-7100, for Quidel Corporation;
or Sharon Platt, Investor Relations Associate, +1-858-552-7955,
or S. Wayne Kay,President & COO, +1-858-646-8063,
both of Quidel Corporation;
or Karen Nelson of McKessonHBOC, +1-804-264-7562